Company profile for Sumitomo Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Sumitomo Pharma, we are focusing our efforts on the research and development of innovative and useful pharmaceuticals as well as healthcare solutions, in the relentless pursuit of our mission: To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045
Telephone
Telephone
+81 662035321
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-that-the-european-medicines-agency-has-granted-orphan-drug-designation-to-nuvisertib-tp-3654-for-the-treatment-of-myelofibrosis-302517571.html

PR NEWSWIRE
30 Jul 2025

https://www.prnewswire.com/news-releases/sumitomo-pharma-america-and-former-professional-quarterback-rodney-peete-say-its-time-to-go-and-put-yourself-first-with-overactive-bladder-treatment-option-gemtesa-302494429.html

PR NEWSWIRE
30 Jun 2025

https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-that-nuvisertib-tp-3654-has-received-fda-fast-track-designation-for-the-treatment-of-myelofibrosis-302480390.html

PR NEWSWIRE
12 Jun 2025

https://www.prnewswire.com/news-releases/sumitomo-pharma-america-enters-into-a-cooperative-research-and-development-agreement-with-the-national-cancer-institute-to-advance-clinical-understanding-of-enzomenib-302426994.html

PR NEWSWIRE
14 Apr 2025

https://www.businesswire.com/news/home/20250130250337/en

BUSINESSWIRE
30 Jan 2025

https://www.businesswire.com/news/home/20250119375255/en

BUSINESSWIRE
20 Jan 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Sumitomo Pharma and get a quotation

Sumitomo Pharma is a supplier offers 16 products (APIs, Excipients or Intermediates).

Find a price of Lurasidone Hydrochloride bulk with DMF offered by Sumitomo Pharma

Find a price of Zonisamide bulk with DMF offered by Sumitomo Pharma

Find a price of Amrubicin bulk offered by Sumitomo Pharma

Find a price of Droxidopa bulk offered by Sumitomo Pharma

Find a price of Enoxacin bulk offered by Sumitomo Pharma

Find a price of Meropenem bulk offered by Sumitomo Pharma

Find a price of Ranirestat bulk offered by Sumitomo Pharma

Find a price of Rimacalib bulk offered by Sumitomo Pharma

Find a price of Sm-216601 bulk offered by Sumitomo Pharma

Find a price of Smp 797 bulk offered by Sumitomo Pharma

Find a price of Sparfloxacin bulk offered by Sumitomo Pharma

Find a price of SMP-028 bulk offered by Sumitomo Pharma

Find a price of SMP-986 bulk offered by Sumitomo Pharma

Find a price of Blonanserin bulk offered by Sumitomo Pharma

Find a price of Mosapride Citrate bulk offered by Sumitomo Pharma

Find a price of Sodium Hyaluronate bulk offered by Sumitomo Pharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty